Live Breaking News & Updates on Timothyc Jenkins

Stay updated with breaking news from Timothyc jenkins. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ERADICATE phase 3 study results highlight the potential

Late breaker presentation at IDWeek 2022First double-blind registrational phase 3 study in Staphylococcus aureus bacteremiaCeftobiprole non-inferior to. ....

Basel Stadt , United States , Mikael Saulay , Marc Engelhardt , Sarahb Doernberg , Sarae Cosgrove , Timothyc Jenkins , Daniel Ionescu , Ivan Titov , Nicholasa Turner , Harald Seifert , Vanceg Fowler Jr , Boiko Atanasov , Oleksandr Pavlov , Maziar Assadi Gehr , Thomasl Holland , Basel Allschwil , Mark Jones , Thomas Holland , Kamal Hamed , Data Review Committee , Drug Administration , Basilea Pharmaceutica Ltd , Pharmaceutica Ltd , Chief Medical Officer , Associate Professor ,

Basilea Pharmaceutica AG: Basilea announces late breaking presentation on the successfully completed ERADICATE phase 3 study with ceftobiprole in Staphylococcus aureus bacteremia (SAB) at IDWeek 2022

First presentation of ERADICATE phase 3 study dataStudy met its primary and secondary endpoints comparing ceftobiprole versus daptomycin with or without aztreonam Basel/Allschwil, Switzerland, October ....

United States , South Africa , Basel Stadt , Republic Of South Africa , Nils Schr , Mikael Saulay , Marc Engelhardt , Sarahb Doernberg , Sarae Cosgrove , Daniel Ionescu , Timothyc Jenkins , Ivan Titov , Nicholasa Turner , Harald Seifert , Vanceg Fowler Jr , Boiko Atanasov , Oleksandr Pavlov , Maziar Assadi Gehr , Thomasl Holland , Basel Allschwil , Mark Jones , Thomas Holland , Kamal Hamed , Us Department Of Health , Human Services , Head Of Corporate Communications Investor Relations ,